Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial
Authors:
Open Access
- 20 September 2006
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (8) , 1207-1213
Abstract
Summary: Aim: To assess the effects of iron removal on cytochrome P450 2E1 activity and oxidative stress in dysmetabolic iron overload syndrome.Methods: Forty‐eight patients were randomized to phlebotomy therapy consisting of removal of 300–500 mL of blood every 14 days until serum ferritin levels dropped under 100 μg/L or to follow‐up without phlebotomy therapy. Cytochrome P450 2E1 activity was measured at baseline and at the end of treatment by using the 6‐hydroxychlorzoxazone/chlorzoxazone blood metabolic ratio, 2 h after the intake of 500 mg of chlorzoxazone.Results: In the treatment group, a mean of 3.9 ± 1.3 L of blood was removed and serum ferritin levels dropped from 715 ± 397 to 74 ± 34 μg/L. Variation of cytochrome P450 2E1 activity was not significantly different between the 2 groups (0.07 ± 0.26 vs. 0.03 ± 0.19, P = 0.36). In the treatment group, low‐density lipoprotein cholesterol and vitamin E were lowered after treatment compared with control group (−0.15 ± 0.51 vs. 0.24 ± 0.58, P = 0.002 and −1.3 ± 4.4 vs. 2.3 ± 5.2, P = 0.03, respectively). Inversely, vitamin C was increased (0.5 ± 3.5 vs. −1.8 ± 3.9, P = 0.03).Conclusions: In dysmetabolic iron overload syndrome, reduction of iron stores does not significantly influence cytochrome P450 2E1 activity but is associated with a significant decrease of low‐density lipoprotein cholesterol, suggesting that venesection therapy may be a suitable option in these patients.Keywords
This publication has 23 references indexed in Scilit:
- Increased urinary excretion of 8-iso-prostaglandin F2α in patients with HFE-related hemochromatosis: A case-control studyFree Radical Biology and Medicine, 2006
- Iron and insulin resistanceAlimentary Pharmacology & Therapeutics, 2005
- Effects of venesections and restricted diet in patients with the insulin‐resistance hepatic iron overload syndromeLiver International, 2004
- Cyp2e1 Activity Before and After Weight Loss in Morbidly Obese Subjects With Nonalcoholic Fatty Liver DiseaseHepatology, 2003
- Histologic Features of the Liver in Insulin Resistance–Associated Iron OverloadAmerican Journal of Clinical Pathology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Insulin resistance–associated hepatic iron overloadGastroenterology, 1999
- Hepatotoxicity induced by iron overload and alcoholJournal of Hepatology, 1996
- Ascorbic Acid Status in Idiopathic HemochromatosisDigestion, 1978
- MEASUREMENT OF LIVER-IRON CONCENTRATION IN NEEDLE-BIOPSY SPECIMENSThe Lancet, 1971